stockrowAvantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.
- Revenue
- +4.59%
- EPS
- +128.9%
- Free cash flow
- −9.03%
- Total debt
- −4.51%
Quarter to September 2026, against a year earlier
Follow AVTR
Alert me
Avantor, Inc. (AVTR) Net income
Avantor, Inc.'s net income for fiscal 2025 was −$530.2M, compared with $711.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was $337.2M. Over the past ten years it has ranged from −$530.2M (fiscal 2025) to $711.5M (fiscal 2024) — the current reading is the lowest in ten years. Avantor, Inc. ranks 10th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$530.2M | — |
| FY2024 | $711.5M | 121.58% |
| FY2023 | $321.1M | (53.23%) |
| FY2022 | $686.5M | 19.89% |
| FY2021 | $572.6M | 391.08% |
| FY2020 | $116.6M | 208.47% |
| FY2019 | $37.8M | — |
| FY2018 | −$86.9M | — |
| FY2017 | −$145.3M | — |
| FY2016 | −$42.0M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $203.4M | 433.86% |
| Jun 2026 | $38.1M | (12.01%) |
| Mar 2026 | $43.3M | (17.37%) |
| Dec 2025 | $52.4M | — |
| 31 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| COO The Cooper Companies, Inc. compare | $570.3M |
| ALGN Align Technology, Inc. compare | $413.6M |
| AVTR Avantor, Inc. | $337.2M |
| ATR AptarGroup, Inc. compare | $267.9M |
| SOLV Solventum Corporation compare | $156.0M |
| RGEN Repligen Corporation compare | −$11.8M |
| BLCO Bausch + Lomb Corporation compare | −$103.0M |
| BAX Baxter International Inc. compare | −$723.0M |
| TFX Teleflex Incorporated compare | −$1.0B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on AVTR
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement